Perbedaan Organon Pharma Indonesia Tbk. dan Rohartindo Nusantara Luas Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Rohartindo Nusantara Luas Tbk. diperdagangkan di Rp69 (kapitalisasi pasar 143,5 M, volume 24 jam 19,25 jt). Perbedaan utamanya: Rohartindo Nusantara Luas Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TOOL | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 143,5 M |
Volume | — | 19,25 jt |
Lot | — | 192,51 rb |
Perputaran | — | 1,31 M |
Harga Rata-rata | — | 67,97 |
Nilai Transaksi | — | 1,31 M |
Harga Ekuilibrium Indikatif | — | 69 |
Volume Ekuilibrium Indikatif | — | 901 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Rohartindo Nusantara Luas Tbk ("The Company") was established based on Notarial Deed of Sudiono Abady, S.H., No. 2 dated October 4, 2014. The Company started its commercial operations in June 2015.
Selengkapnya di halaman TOOL →